A5037913960- Colorectal Cancer Screening and Detection
- Diverticular Disease and Complications
- Gastric Cancer Management and Outcomes
- Colorectal Cancer Surgical Treatments
- Genetic factors in colorectal cancer
Instituto de Investigación Sanitaria Aragón
2012-2023
Hospital Clínico Universitario Lozano Blesa
2023
Onkologikoa
2013
Policlínica Gipuzkoa
2013
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
2013
Instituto Murciano de Investigación Biosanitaria
2013
Departamento de Salud
2013
University Hospital Complex Of Vigo
2013
Complexo Hospitalario Universitario A Coruña
2013
Hospital Universitario de Canarias
2013
Colonoscopy and fecal immunochemical testing (FIT) are accepted strategies for colorectal-cancer screening in the average-risk population.
Screening for colorectal cancer with sigmoidoscopy benefits from the fact that distal findings predict risk of advanced proximal neoplasms (APNs). This study was aimed at comparing existing strategies postsigmoidoscopy referral to colonoscopy in terms accuracy and resources needed. Asymptomatic individuals aged 50–69 years were eligible a randomized controlled trial designed compare fecal immunochemical test. Sigmoidoscopy yield estimated results obtained arm according three sets criteria...
Background Colonoscopy screening is underused by first-degree relatives (FDRs) of patients with non-syndromic colorectal cancer (CRC) completion rates below 50%. Studies conducted in FDR referred for suggest that fecal immunochemical testing (FIT) was not inferior to colonoscopy terms diagnostic yield and tumor staging, but uptake FIT has yet been tested this population. In study, we investigated whether the superior familial-risk population, an equivalent effect on CRC detection. Methods...